ArticleDiagnostics (Basel, Switzerland)2025
Tips for Hepatologist Referral of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease with Alanine Aminotransferase Levels ≤ 30 U/L.
Abstract read
In one paragraph
Article in Diagnostics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Identifying MASLD Patients with MASH or Significant Fibrosis: The Role of Lower ALT Thresholds.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
38 authors.
Miwa KawanakaDepartment of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Okayama 700-8558, Japan.
Hideki FujiiDepartment of Hepatology, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8586, Japan.
Michihiro IwakiDepartment of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Yokohama 232-0024, Japan.
Hideki HayashiDepartment of Gastroenterology and Hepatology, Gifu Municipal Hospital, Gifu 500-8513, Japan.ORCID 0000-0003-0632-907X
Hidenori ToyodaDepartment of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki 503-8502, Japan.ORCID 0000-0002-1652-6168
Satoshi OedaLiver Center, Saga University Hospital, Saga 849-8501, Japan.
Hideyuki HyogoHyogo Life Care Clinic Hiroshima, Hiroshima 732-0823, Japan.
Asahiro MorishitaDepartment of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Takamatsu 761-0793, Japan.ORCID 0000-0002-0760-3045
Kensuke MunekageDepartment of Gastroenterology, Kochi Prefectural Hata Kenmin Hospital, Kochi 788-0785, Japan.
Kazuhito KawataHepatology Division, Department of Internal Medicine II, Hamamatsu University School of Medicine, Shizuoka 431-3192, Japan.ORCID 0000-0002-4986-8578
Tsubasa TsutsumiDivision of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan.ORCID 0000-0001-6571-9874
Koji SawadaDivision of Gastroenterology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa 078-8510, Japan.ORCID 0000-0002-9708-4786
Tatsuji MaeshiroFirst Department of Internal Medicine, University of the Ryukyus Hospital, Okinawa 903-0215, Japan.
Hiroshi TobitaDepartment of Hepatology, Shimane University Hospital, Izumo 693-8501, Japan.ORCID 0000-0003-2408-2023
Yuichi YoshidaDepartment of Gastroenterology and Hepatology, Suita Municipal Hospital, Osaka 564-8567, Japan.
Masafumi NaitoDepartment of Gastroenterology and Hepatology, Suita Municipal Hospital, Osaka 564-8567, Japan.
Asuka ArakiPathology Division, Shimane University Hospital, Izumo 693-8501, Japan.ORCID 0000-0002-2185-4828
Shingo ArakakiFirst Department of Internal Medicine, University of the Ryukyus Hospital, Okinawa 903-0215, Japan.
Takumi KawaguchiDivision of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan.ORCID 0000-0002-7064-4325
Hidenao NoritakeHepatology Division, Department of Internal Medicine II, Hamamatsu University School of Medicine, Shizuoka 431-3192, Japan.ORCID 0000-0003-3649-5335
Masafumi OnoDivision of Innovative Medicine for Hepatobiliary & Pancreatology, Faculty of Medicine, Kagawa University, Takamatsu 760-0793, Japan.
Tsutomu MasakiDepartment of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Takamatsu 761-0793, Japan.
Satoshi YasudaDepartment of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki 503-8502, Japan.
Eiichi TomitaDepartment of Gastroenterology and Hepatology, Gifu Municipal Hospital, Gifu 500-8513, Japan.ORCID 0000-0003-2836-0414
Masato YonedaDepartment of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Yokohama 232-0024, Japan.ORCID 0000-0001-7815-549X
Akihiro TokushigeDepartment of Clinical Pharmacology, Therapeutics School of Medicine, University of the Ryukyus, Okinawa 903-0213, Japan.
Yoshihiro KamadaDepartment of Advanced Metabolic Hepatology, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.ORCID 0000-0001-5485-902X
Hirokazu TakahashiLiver Center, Saga University Hospital, Saga 849-8501, Japan.ORCID 0000-0003-1900-4389
Shinichiro UedaDepartment of Clinical Pharmacology, Therapeutics School of Medicine, University of the Ryukyus, Okinawa 903-0213, Japan.
Shinichi AishimaDepartment of Scientific Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Ken NishinoDepartment of General Internal Medicine 2, Kawasaki Medical Center, Kawasaki Medical School, Okayama 700-8505, Japan.
Katsunori IshiiDepartment of General Internal Medicine 2, Kawasaki Medical Center, Kawasaki Medical School, Okayama 700-8505, Japan.
Takashi FushimiDepartment of General Internal Medicine 2, Kawasaki Medical Center, Kawasaki Medical School, Okayama 700-8505, Japan.
Hirofumi KawamotoDepartment of General Internal Medicine 2, Kawasaki Medical Center, Kawasaki Medical School, Okayama 700-8505, Japan.
Yoshio SumidaGraduate School of Healthcare Management, International University of Healthcare and Welfare, Tokyo 107-8402, Japan.ORCID 0000-0002-4342-1361
Takeshi OkanoueDepartment of Gastroenterology and Hepatology, Saiseikai Suita Hospital, Osaka 564-0013, Japan.ORCID 0000-0002-2390-3400
Atsushi NakajimaDepartment of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Yokohama 232-0024, Japan.ORCID 0000-0002-6263-1436
Japan Study Group Of Nonalcoholic Fatty Liver Disease Jsg-Nafld
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
alanine transaminasediabetes mellitus type-2FIB-4 indexMASLDNara Declaration 2023
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.